Ahmad Owais M, Ibrahim Ruba, Odunsi Daniella I, Mohammed Mahdi, Mathew Bobby George, Touny Mohamed, Grewal Bhupinder S, Bhanot Shubham, Bodapati Neeraj, Thomas George Pandarakalam, Nv Shreyas, Masood Lalain, Morani Zoya
Internal Medicine, Charles University, Hradec Kralove, CZE.
Medicine and Surgery, University of Medical Sciences and Technology (UMST), Khartoum, SDN.
Cureus. 2025 May 7;17(5):e83673. doi: 10.7759/cureus.83673. eCollection 2025 May.
Cardiovascular disease (CVD) is a leading cause of death worldwide. A key area of interest in CVD prevention is novel digital health technologies, primarily mobile health (mHealth) applications and wearable devices, that are rapidly transforming the methods of preventing and managing CVD. Studies have shown the success of smartphone applications, such as the RITMIA app (Heart Sentinel™, Parma, Italy), in successfully detecting atrial fibrillation (Afib) compared to a classic 12-lead electrocardiogram (ECG). mHealth devices should integrate these factors, based on artificial intelligence (AI) and driven by chatbots, to encourage patients to use technology through interactive, real-world, motivational, and timely feedback. Data from mHealth clinical research indicate improved medication adherence, weight control, and self-care among patients. This review highlights mHealth and wearable devices in CVD prevention, providing foresight into cardiovascular health conditions through continuous monitoring, early detection, and improved patient engagement. Additionally, it examines challenges, including ethical, regulatory, and accessibility issues, that need to be addressed before their widespread adoption. In the future, the priority must be integration with healthcare systems and equitable access. A thorough search was conducted using reputable databases such as Scopus, PubMed, and Google Scholar. Articles from 2015 to 2025, along with an article from 2002 published in reputable peer-reviewed journals, were analyzed and contextually used. We also refined our search terms and used high-quality English articles to achieve this.
心血管疾病（CVD）是全球主要的死亡原因。CVD预防的一个关键关注领域是新型数字健康技术，主要是移动健康（mHealth）应用程序和可穿戴设备，它们正在迅速改变CVD的预防和管理方法。研究表明，与传统的12导联心电图（ECG）相比，智能手机应用程序，如RITMIA应用程序（Heart Sentinel™，意大利帕尔马），在成功检测心房颤动（Afib）方面取得了成功。mHealth设备应基于人工智能（AI）并由聊天机器人驱动，整合这些因素，通过交互式、真实世界、激励性和及时的反馈来鼓励患者使用技术。mHealth临床研究数据表明患者的药物依从性、体重控制和自我护理得到了改善。本综述重点介绍了mHealth和可穿戴设备在CVD预防中的作用，通过持续监测、早期检测和改善患者参与度，对心血管健康状况进行前瞻性分析。此外，它还探讨了在广泛采用之前需要解决的挑战，包括伦理、监管和可及性问题。未来，重点必须是与医疗保健系统整合以及公平获取。我们使用了Scopus、PubMed和谷歌学术等知名数据库进行了全面搜索。分析并结合使用了2015年至2025年的文章，以及2002年发表在知名同行评审期刊上的一篇文章。我们还优化了搜索词，并使用高质量的英文文章来实现这一目标。
